These effects presumably would mirror those of ghrelin demonstrated in several preclinical cachexia and muscle atrophy models and in cachectic patients with heart failure and chronic obstructive pulmonary disease [83], [85], [86], [87], [88], [89]. This evidence concerns the gene GHRL and chronic obstructive pulmonary disease.